Sino-Life Group Limited (8296) AI Stock Analysis

0 Followers

Sino-Life Group Limited

(HKEX:8296)

Select Model

Rating:46.9Neutral

Price Target:HKD 0.16▼(-1.81% Downside)

Action:upgraded

Date:10/21/26

Weak profitability and cash generation are the primary constraints, despite balance-sheet resilience and favorable short-term price momentum. The negative P/E and lack of dividend support further limit the score, while highly overbought technical conditions add risk.

Positive Factors

Balance-sheet flexibilityLower leverage than in earlier years indicates a comparatively steadier balance sheet and more financial flexibility. This can help the company sustain operations and fund priorities while it works to improve profitability, although ongoing losses remain a constraint.

Negative Factors

Persistent net lossesRecurring net losses weaken retained capital and indicate that the business has not yet converted its operations into sustainable shareholder earnings. Continued losses could erode the equity base over time and restrict the company’s ability to fund growth internally.

Sino-Life Group Limited (8296) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 15.12M
Dividend Yield: ―
Average Volume (3M): 25.87K
Price to Earnings (P/E): -0.7
Beta (1Y): -0.31
Revenue Growth: -26.00%
EPS Growth: -188.55%
Country: Hong Kong
Employees: 134
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Personal Products & Services

Sino-Life Group Limited Business Overview & Revenue Model

Company Description

Sino-Life Group Limited, an investment holding company, provides funeral and related services in the People’s Republic of China, Taiwan, Hong Kong, and Vietnam. It operates in two segments, Funeral Services; and Biotechnical and other businesses. The...

Sino-Life Group Limited Financial Statement Overview

Summary

Revenue contraction, persistent net and EBIT losses, and deeply negative operating and free cash flow weigh heavily on performance. The solid equity base and declining debt-to-equity ratio provide partial support.

Income Statement

32Negative

Balance Sheet

68Positive

Cash Flow

25Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	39.34M	64.38M	74.94M	72.57M	77.97M	72.86M
Gross Profit	14.02M	30.95M	32.28M	33.48M	39.80M	37.98M
EBITDA	-12.06M	-2.37M	174.00K	1.70M	17.78M	-4.28M
Net Income	-16.47M	-6.56M	-8.70M	-7.17M	-847.00K	-9.87M
Balance Sheet
Total Assets	207.59M	229.53M	250.63M	271.71M	284.79M	263.85M
Cash, Cash Equivalents and Short-Term Investments	127.48M	133.16M	148.63M	173.51M	180.59M	156.13M
Total Debt	19.29M	21.79M	29.68M	37.43M	27.90M	33.49M
Total Liabilities	121.75M	131.29M	147.09M	163.17M	153.97M	158.27M
Stockholders Equity	109.17M	120.42M	123.45M	123.72M	113.22M	114.61M
Cash Flow
Free Cash Flow	-2.91M	-6.22M	-8.97M	-3.04M	7.77M	-4.31M
Operating Cash Flow	-2.91M	-4.85M	-8.21M	-2.60M	10.24M	-407.00K
Investing Cash Flow	2.77M	2.08M	-3.30M	17.36M	-32.20M	-1.83M
Financing Cash Flow	-2.09M	-7.40M	-2.10M	-7.66M	18.77M	-7.75M

Sino-Life Group Limited Technical Analysis

Technical Analysis SentimentNeutral

Last Price0.17

Price Trends

50DMA0.17Positive

100DMA0.16Positive

200DMA0.24Negative

Market Momentum

MACD-0.00Positive

RSI48.74Neutral

STOCH36.94Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8296, the sentiment is Neutral. The current price of 0.17 is below the 20-day moving average (MA) of 0.18, above the 50-day MA of 0.17, and below the 200-day MA of 0.24, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 48.74 is Neutral, neither overbought nor oversold. The STOCH value of 36.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8296.

Sino-Life Group Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

HK:8296 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:1830	77Outperform	HKD 1.96B	10.96	43.78%	9.32%	-14.68%	-13.60%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
HK:1448	56Neutral	HKD 6.03B	14.04	6.50%	6.27%	―	―
HK:0922	52Neutral	HKD 202.14M	-1.74	-13.22%	17.58%	-16.99%	-326.96%
HK:2521	52Neutral	HKD 1.76B	48.42	6.47%	―	2.78%	-41.23%
HK:0919	48Neutral	HKD 67.84M	-37.50	-0.93%	―	-2.31%	66.07%
HK:8296	47Neutral	HKD 14.93M	-0.67	-17.95%	―	-26.00%	-188.55%

* Consumer Cyclical Sector Average

Performance Comparison

HK:8296 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:8296	Sino-Life Group Limited	0.17	-0.21	-56.32%
HK:1448	Fu Shou Yuan International Group	2.64	-0.27	-9.31%
HK:0919	Modern Healthcare Technology Holdings Limited	0.07	0.00	2.74%
HK:0922	Anxian Yuan China Holdings Limited	0.09	-0.05	-35.92%
HK:1830	Perfect Medical Health Management Limited	1.56	0.33	26.62%
HK:2521	Shenghui Cleanness Group Holdings Limited	0.91	0.43	88.54%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 21, 2026

Sino-Life Group Limited AI Stock Analysis